EZH2 and breast cancer: A functional link between GATA3 expression and the histone methyltransferase enhancer of zeste homolog 2 (EZH2) has been suggested, since EZH2 knockdown in basal-like breast cancer cells promotes the increase of GATA3 expression levels [21].